Founded with the mission to bridge the gap between doctors and clinical trials, SelectIQ leverages electronic health records to streamline patient recruitment for drug development. The company aims to address the significant challenge in clinical trials: recruiting patients. By enabling doctors to easily inform their patients about relevant clinical trials, SelectIQ aspires to enhance the efficiency and effectiveness of drug development, ultimately bringing safer and more effective treatments to market.
SelectIQ has garnered notable affiliations, including strategic advisor Dan Sfera, who brings extensive expertise in clinical trial operations. The company's innovative approach has significantly impacted the clinical trial landscape by reducing the burden on trial sites and healthcare providers. Through its Provider Activation Platform, SelectIQ has made substantial strides in automating and optimizing the referral network, thereby improving patient participation rates and expediting the drug development process.
